Sign in
Taking people in United StatesNo phase

Exercise study of fitness and lungs in young people with childhood illness

Studies fitness and lung function in young people after leukemia, heart transplant, or lung disease.

Key facts

Who runs it
Masonic Cancer Center, University of Minnesota
Where
Minneapolis, United StatesSee the site
Trial code
Registry title
Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
Status
Recruiting
People taking part
90 people, planned
Started
14 Mar 2025
Expected to end
1 Dec 2026
Type of study
Observational, 2 groups
Treatments tested
  • Physical activity
Record updated
24 November 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and young people aged 8 to 25. They are either survivors of acute lymphoblastic leukemia, or live with chronic lung disease of prematurity, or live with a heart transplant. Healthy controls can also join.

Age
8 to 25 years old
Sex
All sexes
Disease stage
Acute lymphoblastic leukemia survivors (therapy finished at least 3 months before joining), chronic lung disease of prematurity, or a heart transplant. Healthy controls also join.
Earlier treatment
Leukemia survivors must have finished therapy at least 3 months before joining. Leukemia survivors who had cranial radiation or a bone marrow transplant cannot join.
Biomarker or test result
Blood oxygen (SpO2) above 92% for people with a condition, above 95% for controls. Blood pressure below the 95th percentile for age; blood pressure medicine is okay.

Main reasons for not taking part

  • Leukemia survivors who had cranial radiation
  • Leukemia survivors who had a bone marrow transplant
  • Controls with a history of cancer, chronic lung disease or heart transplant
  • Controls with a history of arrhythmia or known heart problems
  • The investigator or primary doctor thinks the person is unsuitable for the study

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Cases:; Acute lymphoblastic leukemia survivor, OR living with chronic lung disease of prematurity, OR living with heart transplant; 8-25 years old; Height: ≥ 48 inches; Ambulatory without assistance; English speaking; Normotensive (<95th percentile for age; okay if managed with antihypertensive medication); SpO2 >92%; Not pregnant; ALL survivor specific: must have completed therapy ≥ 3 months prior to study entry
  • Controls; 8-25 years old; Height: ≥ 48 inches; Ambulatory without assistance; English speaking; No history of arrhythmia or known cardiac dysfunction at baseline; Normotensive (<95th percentile for age; okay if managed with antihypertensive medication); SpO2 >95%; Not pregnant

Who cannot take part

  • Cases:; ALL specific: received cranial radiation, bone marrow transplant recipients; Investigator or patient's primary physician deems the patient unsuitable for the study
  • Controls:; History of malignancy, CLD or HT or any other diagnosis which may reduce cardiorespiratory function; Investigator deems the patient unsuitable for the study

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 8 and 25 years old?

Where in United States

  • Masonic Cancer CenterMinneapolis, United StatesContact: Lucie Turcotte, MD, MPH, MSTaking people

About the trial

What the trial wants to find out

This study aims to more accurately assess cardiac function, ventilation and exercise capacity in a non-invasive fashion, and to better characterize exercise intolerance in the setting of three populations of individuals with chronic diseases of childhood (acute lymphoblastic leukemia (ALL), chronic lung disease (CLD) of prematurity, and post-heart transplant (HT))

The 2 groups in the trial

  • Case

    Adolescent or young adult acute lymphoblastic leukemia survivor, OR living with chronic lung disease of prematurity, OR living with heart transplant

    Treatment: Physical activity

  • Control

    14-25 years old healthy individuals who are ambulatory without assistance. We may enroll younger subjects but we wish to subjects to match our patient population

    Treatment: Physical activity

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant Bronchopulmonary Dysplasia (BPD, Also Known as Chronic Lung Disease of Prematurity) Through Exercise (FLASHLITE)
Plain-language title
Exercise study of fitness and lungs in young people with childhood illnessGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT05025774, who can take part
Record updated
24 November 2025